SMFM 27th Annual Meeting 2007
If you are having trouble viewing the Windows Media video, click here for the Flash version.
read the abstract: A Prospective, Randomized Trial of Transcervical Foley Catheter With or Without Oxytocin for Preinduction Cervical Ripening
Transcript
Alix Boyle: Hi, this is Alix Boyle, reporting for OBGYN.net. I am here at the SMFM meeting in San Francisco and today we are speaking with Dr. Chris Pettker from Yale University. Tell us about your research.
Christian Pettker, MD: I studied with my colleagues induction of labor. Induction is a significant problem through pregnancies and to people who care for people in pregnancy. We induce about 20% of pregnancies in the United States, so we are constantly looking for methods that will make it easier and safer to induce a woman to get her into labor. We looked at a technique that uses a Foley balloon, a balloon in the cervix to help soften and dilate the cervix. It is very common that doctors add Oxytocin to this method in order to stimulate contractions and perhaps make inductions faster. There is no evidence to support the use of Oxytocin with this technique, so we looked and we compared women who had the Foley balloon with Oxytocin to women who did not have Oxytocin.
Alix Boyle: What were your results?
Christian Pettker, MD: We found out that overall patients who used the Oxytocin with the Foley balloon did not deliver any sooner or have a lower incidence of Caesarian section than the patients who did not have Oxytocin when we used the Foley balloon technique. So it really says that we should not advocate for Oxytocin use when we use the balloon technique for induction.
Alix Boyle: What was the risk of Oxytocin?
Christian Pettker, MD: We actually found that patients when we were inducing them early in labor and we used the Oxytocin, the patients used epidurals a lot more early in labor and the difference was really significant and that hit us that maybe patients were more uncomfortable with the Oxytocin use early in labor. If there is no difference between using Oxytocin with the Foley balloon in successive induction, then there is the risk of increased use of anesthesia, like epidurals, then that is probably not a good thing for us to use.
Alix Boyle: Okay. Sounds like a really interesting study.
Christian Pettker, MD: Thank you.
Alix Boyle: That was Dr. Chris Pettker from Yale University.
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More